The histopathologic evaluation of soft tissue changes in rabbit extremity after different dose-fractionation schemes of interstitial high dose rate (HDR) brachytherapy

Reports of Practical Oncology and Radiotherapy

Volumn 15, Issue 6, 2010, Pages 165-171

  Erpolat, Ozge Petek ^a   Akmansu, Muge ^a   Dogan, Mehmet ^b   Bora, Huseyin ^a   Kurugol, Ceren ^a   Uluoglu, Omer ^c  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Gaziantep Avukat Cengiz Gokcek Government Hospital   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

Dose and fractionation; Interstitial HDR brachytherapy; Soft tissue

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BRACHYTHERAPY; CALCIFICATION; EDEMA; FIBROSIS; HISTOPATHOLOGY; HYALINE DEGENERATION; INFLAMMATION; LIMB; MALE; NECROSIS; NONHUMAN; RABBIT; RADIATION DOSE FRACTIONATION; SOFT TISSUE; SOFT TISSUE SARCOMA;

EID: 78649791822     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2010.09.002     Document Type: Article

References (41)

1. Rezvani M., Hopewell J.W., Robbins M.E. Initiation of non-neoplastic late effects: the role of endothelium and connective tissue. Stem Cells 1995, 13:248-256.
2. Stone H.B., Coleman C.N., Anscher M.S., McBride W.H. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003, 4:529-536.
3. Davis A.M., Dische S., Gerber L., Saunders M., Leung S.F., O'Sullivan B. Measuring postirradiation subcutaneous soft-tissue fibrosis: state of the art and future directions. Semin Radiat Oncol 2003, 13:203-213.
4. O'Sullivan B., Levin W. Late radiation-related fibrosis: pathogenesis, manifestations, and current management. Semin Radiat Oncol 2003, 13:274-289.
5. Radiobiology for the radiologist. 1996, Lippincott W&W, Philadelphia. E.J. Hall, A.T. Giaccia (Eds.).
6. Steel G.G. Cell survival as a determinant of tumour response. Basic clinical radiobiology 2002, 52-63. Arnold, London. 3th ed. G.G. Steel (Ed.).
7. Baumann M., Saunders M.I., Joiner M.C. Modified fractionation. Basic clinical radiobiology 2002, 147-157. Arnold, London. 3rd ed. G.G. Steel (Ed.).
8. de Wit R., Smit W.G., Veenhof K.H., Bakker P.J., Oldenburger F., Gonzalez D.G. Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800cGy. Radiother Oncol 1990, 19:131-136.
9. McBride W.H. Biologic basis of radiation therapy. Principles and practice of radiation oncology 2004, 96-136. Lippincott W&W, Philadelphia. 4th ed. C.A. Perez, L.W. Brady, E.C. Halperin, R.K. Schmidt-Ullrich (Eds.).
10. Stein M., Spencer D., Kantor A., et al. Radiation therapy in epidemic. AIDS-related Kaposi's sarcoma in Southern Africa. Tumori 1994, 80:216-219.
11. Kretzler A., Molls M., Gradinger R., Lukas P., Steinav H.U., Würschmidt F. Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Oncol 2004, 180:365-370.
12. Van Kampen M., Eble M.J., Lehnert T., et al. Correlation of intraoperatively irradiated volume and fibrosis in patients with soft-tissue sarcoma of the extremities. Int J Radiat Oncol Biol Phys 2001, 51:94-99.
13. Ballo M.T., Lee A.K. Current results of brachytherapy for soft-tissue sarcoma. Curr Opin Oncol 2003, 15:313-318.
14. Koizumi M., Inoue T., Yamazaki H., et al. Perioperative fractionated high-dose rate brachytherapy for malignant bone and soft tissue tumors. Int J Radiat Oncol Biol Phys 1999, 43:989-993.
15. Petera J., Neumanova R., Odrazka K., et al. Perioperative fractionated high-dose rate brachytherapy in the treatment of soft tissue sarcomas. Neoplasma 2004, 51:59-63.
16. Skowronek J., Zwierzchowski G., Piotrowski T. Pulsed dose rate brachytherapy-description of a method and a review of clinical applications. Rep Pract Oncol Radiother 2001, 6:197-202.
17. Nag S., Tippin D., Ruymann F.B. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas. J Pediatr Hematol Oncol 2003, 25:448-452.
18. Kehwar T.S., Akber S.F. Assessment of tumor control probability for high-dose-rate interstitial brachytherapy implants. Rep Pract Oncol Radiother 2008, 13:74-77.
19. Aygenc E., Celikkanat S., Bilgili H., et al. Pentoxifylline effects on acute and late complications after radiotherapy in rabbit. Otolaryngol Head Neck Surg 2001, 124:669-673.
20. Ekholm M., Helander P., Hietanen J., et al. A histological and immunohistochemical study of tissue reactions to solid poly (ortho ester) in rabbits. Int J Oral Maxillofacial Surg 2006, 35:631-635.
21. Karacaoglu E., Bayram I., Celiköz B., Zienowicz R.J. Does sustained epinephrine release trigger a hypoxia-neovascularization cascade?. Plast Reconstr Surg 2007, 119:858-864.
22. Whalen R.L., Bowen M.A., Fukumura F., et al. The effects of radiation therapy on the tissue capsule of soft tissue implants. ASAIO J 1994, 40:365-370.
23. Halperin E.C., Schmidt-Ullrich R.K., Perez C.A., Brady L.W. The discipline of radiation oncology. Principles and practice of radiation oncology 2004, 1-95. Lippincott W&W, Philadelphia. 4th ed. C.A. Perez, L.W. Brady, E.C. Halperin, R.K. Schmidt-Ullrich (Eds.).
24. Bentzen S.M., Baumann M. The linear-quadratic model in clinical practice. Basic clinical radiobiology 2002, 134-146. Arnold, London. 3rd ed. G.G. Steel (Ed.).
25. Baker D.G., Leith J.J. Effect of dose rate on production of early and late radiation damage in mouse skin. Int J Radiat Oncol Biol Phys 1977, 2:69-77.
26. Futran N.D., Trotti A., Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations. Laryngoscope 1997, 107:391-395.
27. Coucke P.A., Guillemin C.L., Mirimanoff R.O. The role of radiotherapy in the treatment of soft tissue sarcomas. Bull Cancer Radiother 1993, 80:13-26.
28. Nag S. Clinical aspects of high-dose-rate brachytherapy. Principles and practice of radiation oncology 2004, 619-635. Lippincott W&W, Philadelphia. 4th ed. C.A. Perez, L.W. Brady, E.C. Halperin, R.K. Schmidt-Ullrich (Eds.).
29. Nag S., Fernandes P.S., Martinez-Monge R., Ruymann F.B. Use of brachytherapy to preserve function in children with soft-tissue sarcomas. Oncology 1999, 13:361-374.
30. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 2006, 6:702-713.
31. Baumann M., Bentzen S.M. Clinical manifestation of normal tissue damage. Basic clinical radiobiology 2002, 105-119. Arnold, London. 3rd ed. G.G. Steel (Ed.).
32. Van Der Kogel A.J. Radiation response and tolerance of normal tissues. Basic clinical radiobiology 2002, 30-41. Arnold, London. 3rd ed. G.G. Steel (Ed.).
33. Sener G., Kabasakal L., Atasoy B.M., et al. Ginkgo biloba extract protects against ionizing radiation-induced oxidative organ damage in rats. Pharmacol Res 2006, 53:241-252.
34. Baker D.G., Krochak R.J. The response of the microvascular system to radiation: a review. Cancer Invest 1989, 7:287-294.
35. Robbins and Cotran pathologic basis of disease 2005, Elsevier Saunders, Philadelphia. V. Kumar, A.K. Abbas, N. Fausto (Eds.).
36. Ekholm M., Helander P., Hietanen J., et al. A histological and immunohistochemical study of tissue reactions to solid poly (ortho ester) in rabbits. Int J Oral Maxillofac Surg 2006, 35:631-635.
37. Stewart F.A., Van der Kogel A.T. Proliferative and cellular organization of normal tissues. Basic clinical radiobiology 2002, 24-25. Arnold, London. 3rd ed. G.G. Steel (Ed.).
38. Milliat F., François A., Isoir M., et al. Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol 2006, 169:1484-1495.
39. Herskind C., Bentzen S.M., Overgaard J., Overgaard M., Bamberg M., Rodemann H.P. Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol 1998, 47:263-269.
40. Bentzen S.M., Thames H.D., Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single follow-up clinical study. Radiother Oncol 1989, 15:267-274.
41. Fowler J.F. Brief summary of radiobiological principles in fractionated RT. Semin Radiat Oncol 1992, 2:16-21.